1.40BMarket Cap-7753P/E (TTM)
24.350High23.170Low274.38KVolume23.170Open23.170Pre Close6.51MTurnover0.73%Turnover RatioLossP/E (Static)57.63MShares30.18952wk High3.29P/B914.27MFloat Cap7.64052wk Low--Dividend TTM37.67MShs Float59.850Historical High--Div YieldTTM5.09%Amplitude7.300Historical Low23.713Avg Price1Lot Size
Cullinan Therapeutics Stock Forum
NEWS
Cullinan Therapeutics to Present Clinical Data from Phase 1 Study Evaluating Novel Anti-MICA/B Antibody, CLN-619, as Monotherapy and in Combination with a Checkpoint Inhibitor in Patients with Advanced Solid Tumors at ASCO 2024
• $Cullinan Therapeutics(CGEM.US)$ +22.4% (Cullinan Management and Taiho Pharmaceutical to collaborate to jointly develop and commercialize CLN081/TAS6417 and Taiho's acquisition of Cullinan Pearl)
• $Lordstown Motors(RIDE.US)$ +17.2% (closes asset purchase agreement with Foxconn)
• $Applovin(APP.US)$ +15.5%(In reaction to earnings)
• $SmartRent(SMRT.US)$ +15.4%(In reaction to earnings)
• $Coupang(CPNG.US)$ +14.3%(In reaction to earn...
No comment yet